Multidisciplinary Management of Orbital Metastasis and Survival Outcomes
Christian El‐Hadad, Bita Esmaeli(Orbital Research (United States)), Kirthi Koka, J. Matthew Debnam(The University of Texas MD Anderson Cancer Center), Thai Do, Wenli Dong, Jing Ning(The University of Texas MD Anderson Cancer Center), Jocelyn D. Ursua, Maryam Haider(NorthShore University HealthSystem)
Cited by 13
Related Papers
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
|Cancer Discovery|2018|570
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
|The Lancet Haematology|2020|330
Sebaceous carcinoma: evidence-based clinical practice guidelines
|The Lancet Oncology|2019|204